0000899243-17-015173.txt : 20170602
0000899243-17-015173.hdr.sgml : 20170602
20170602163752
ACCESSION NUMBER: 0000899243-17-015173
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170531
FILED AS OF DATE: 20170602
DATE AS OF CHANGE: 20170602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: George Simeon
CENTRAL INDEX KEY: 0001595117
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 17888525
MAIL ADDRESS:
STREET 1: 161 WASHINGTON STREET
STREET 2: SUITE 500
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-31
0
0001674416
CRISPR Therapeutics AG
CRSP
0001595117
George Simeon
C/O S.R. ONE LIMITED
161 WASHINGTON ST., SUITE 500
CONSHOHOCKEN
PA
19428
1
0
0
0
Stock Option (Right to Buy)
13.62
2017-05-31
4
A
0
15000
0.00
A
2027-05-31
Common Shares
15000
15000
D
This stock option was granted on May 31, 2017 with respect to 15,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning June 30, 2017. The stock option was granted to the Reporting Person as director's compensation. As a Vice President of S.R. One, Limited and an employee of GlaxoSmithKline LLC, the Reporting Person is obligated to transfer any shares issued under the stock option to S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaoxSmithKline plc.
/s/ Michael Esposito, attorney-in-fact
2017-06-02